↩ Go Back
Need help?

Bio Therapeutic Drugs Company Investment Opportunity in Cambridge, United Kingdom

Drug discovery company with novel drug compounds under trial and a robust R&D infrastructure.
This Business is on a Premium Plan
Established 1-5 year(s)
Employees 5 - 10
Legal Entity Private Limited Company
Reported Sales Nil
Run Rate Sales Nil
EBITDA Margin Nil
Industries Bio Therapeutic Drugs
Locations  Cambridge
Local Time 7:13 AM Asia / Kolkata
Listed By Advisor / Business Broker
Status Active
Overall Rating
Partial Stake Sale
USD 10.5 million for 30.0% stake (Native Currency: INR 877,800,000)
Reason: The owners are seeking an investment to expand the research. The investment will help in: 1. Devel... View More
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview
- The company is a pharmaceutical and healthcare business based in Cambridge, specializing in drug discovery and development of novel drug compounds.
- The company has a small team of 5 employees, with promoters who have over two decades of experience in pharmacology, having worked as scientists at renowned universities in the United Kingdom.
- The company's research and development infrastructure is well-established, and it also offers managed print services and contract research in addition to drug development.
- The focus of the company's research is on finding a cure for Parkinson's disease, with over 130 tests conducted on the drug compound showing a 75% success rate, with an expected increase to over 90% within the next 2 years.
- Upon launch to the public, the company anticipates generating over 90% in profits.
- The company's drug discovery and development process is supported by Indian scholar scientists based in the UK, adding a diverse and skilled team to its research efforts.
- All research documents related to the drug compounds and trials are available for review, providing transparency and insight into the company's research and development activities.
Products & Services Overview
The company specializes in research and development infrastructure, managed print services, contract research, and the development of novel drug compounds.
Assets Overview
Will be disclosed further during the conversation.
Facilities Overview
All facility details will be disclosed to interested investors directly.
Capitalization Overview
The company was initiated based on seed funding from the promoters.
Further information can be disclosed after connection during further conversation.
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
3 Investors contacted this Business this month. Register below to connect now!
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses
    Frequently
    Asked
    Questions
    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more